Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

The development of therapeutic approaches to treat lung disease requires an understanding
of both the normal and disease physiology of the lung. Although traditional experimental …

Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

With the rapid growth of the nanotechnology industry, the need to understand the biological
effects of aerosol exposure has become increasingly important. Featuring contributions by …

Despite the passionate debate over the use of β2‐adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …

This is the fourth version of the updated guidelines for the diagnosis and management of
asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi …

支气管哮喘是一种由多种细胞及细胞组分参与的慢性呼吸道炎性疾病, 可引起反复发作性喘息,
呼吸困难, 胸闷或咳嗽等症状, 还伴有呼吸道对多种刺激因子的反应性增高 …

Engineered porous phospholipid microparticles with aerodynamic diameters in the
respirable range of 1–2 μm were cosuspended in 1, 1, 1, 2-tetrafluoroethane, a propellant …

This is an updated guideline for the diagnosis and management of asthma, developed by
the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The …

Asthma is one of the leading causes of mortality worldwide presenting a huge socio-
economic burden with rising morbidity and mortality rates. It is a chronic inflammatory airway …